Over time, the appetite-suppressing effects often become more predictable as the body adapts to the treatment
Durand, E
From correlation to causation networks: A simple approximate learning algorithm and its application to high-dimensional plant gene expression data
Ozempic has not been studied in people with pancreatic disease
For example, increased activity of the endocannabinoid system does not influence GLP-1 concentrations 74,75 , and the effects of CB1 receptor antagonists on appetite, food intake, and weight are not mediated by GLP-1 76,77
The FDA highlights potential side effects of semaglutide that include nausea, diarrhea, vomiting, headache, and fatigue, and highlights that patients should discuss with their healthcare professional if they have symptoms of pancreatitis or gallstones (among other conditions) before starting treatment